73 related articles for article (PubMed ID: 17032176)
1. Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in Japan.
Kobayashi R; Ariga T; Nonoyama S; Kanegane H; Tsuchiya S; Morio T; Yabe H; Nagatoshi Y; Kawa K; Tabuchi K; Tsuchida M; Miyawaki T; Kato S
Br J Haematol; 2006 Nov; 135(3):362-6. PubMed ID: 17032176
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study.
Moratto D; Giliani S; Bonfim C; Mazzolari E; Fischer A; Ochs HD; Cant AJ; Thrasher AJ; Cowan MJ; Albert MH; Small T; Pai SY; Haddad E; Lisa A; Hambleton S; Slatter M; Cavazzana-Calvo M; Mahlaoui N; Picard C; Torgerson TR; Burroughs L; Koliski A; Neto JZ; Porta F; Qasim W; Veys P; Kavanau K; Hönig M; Schulz A; Friedrich W; Notarangelo LD
Blood; 2011 Aug; 118(6):1675-84. PubMed ID: 21659547
[TBL] [Abstract][Full Text] [Related]
3. The French national registry of primary immunodeficiency diseases.
CEREDIH: The French PID study group
Clin Immunol; 2010 May; 135(2):264-72. PubMed ID: 20399414
[TBL] [Abstract][Full Text] [Related]
4. A multiinstitutional survey of the Wiskott-Aldrich syndrome.
Sullivan KE; Mullen CA; Blaese RM; Winkelstein JA
J Pediatr; 1994 Dec; 125(6 Pt 1):876-85. PubMed ID: 7996359
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation.
Ozsahin H; Cavazzana-Calvo M; Notarangelo LD; Schulz A; Thrasher AJ; Mazzolari E; Slatter MA; Le Deist F; Blanche S; Veys P; Fasth A; Bredius R; Sedlacek P; Wulffraat N; Ortega J; Heilmann C; O'Meara A; Wachowiak J; Kalwak K; Matthes-Martin S; Gungor T; Ikinciogullari A; Landais P; Cant AJ; Friedrich W; Fischer A
Blood; 2008 Jan; 111(1):439-45. PubMed ID: 17901250
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for Wiskott-Aldrich syndrome in a severely affected adult.
Morris EC; Fox T; Chakraverty R; Tendeiro R; Snell K; Rivat C; Grace S; Gilmour K; Workman S; Buckland K; Butler K; Chee R; Salama AD; Ibrahim H; Hara H; Duret C; Mavilio F; Male F; Bushman FD; Galy A; Burns SO; Gaspar HB; Thrasher AJ
Blood; 2017 Sep; 130(11):1327-1335. PubMed ID: 28716862
[TBL] [Abstract][Full Text] [Related]
8. Rare solid tumors in a patient with Wiskott-Aldrich syndrome after hematopoietic stem cell transplantation: case report and review of literature.
Coppola E; Giardino G; Abate M; Tambaro FP; Bifano D; Toriello E; De Rosa A; Cillo F; Pignata C; Cirillo E
Front Immunol; 2023; 14():1229674. PubMed ID: 37781361
[TBL] [Abstract][Full Text] [Related]
9. Confirmed diagnosis of classic Wiskott-Aldrich syndrome in East Africa: a case report.
Kiputa M; Urio O; Maghembe A; Kombo D; Dhalla S; Ndembo V; Muze K; Kahwa M; Fakih Z; Kija E
J Med Case Rep; 2022 Jul; 16(1):301. PubMed ID: 35897083
[TBL] [Abstract][Full Text] [Related]
10. Clinical Features, Cancer Biology, Transplant Approach and Other Integrated Management Strategies for Wiskott-Aldrich Syndrome.
Hosahalli Vasanna S; Pereda MA; Dalal J
J Multidiscip Healthc; 2021; 14():3497-3512. PubMed ID: 34992377
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome and chimerism in patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation: a retrospective nationwide survey.
Iguchi A; Cho Y; Yabe H; Kato S; Kato K; Hara J; Koh K; Takita J; Ishihara T; Inoue M; Imai K; Nakayama H; Hashii Y; Morimoto A; Atsuta Y; Morio T;
Int J Hematol; 2019 Sep; 110(3):364-369. PubMed ID: 31187438
[TBL] [Abstract][Full Text] [Related]
12. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
[TBL] [Abstract][Full Text] [Related]
13. Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome.
Candotti F
J Clin Immunol; 2018 Jan; 38(1):13-27. PubMed ID: 29086100
[TBL] [Abstract][Full Text] [Related]
14. A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome.
Shekhovtsova Z; Bonfim C; Ruggeri A; Nichele S; Page K; AlSeraihy A; Barriga F; de Toledo Codina JS; Veys P; Boelens JJ; Mellgren K; Bittencourt H; O'Brien T; Shaw PJ; Chybicka A; Volt F; Giannotti F; Gluckman E; Kurtzberg J; Gennery AR; Rocha V;
Haematologica; 2017 Jun; 102(6):1112-1119. PubMed ID: 28255019
[TBL] [Abstract][Full Text] [Related]
15. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
Hacein-Bey Abina S; Gaspar HB; Blondeau J; Caccavelli L; Charrier S; Buckland K; Picard C; Six E; Himoudi N; Gilmour K; McNicol AM; Hara H; Xu-Bayford J; Rivat C; Touzot F; Mavilio F; Lim A; Treluyer JM; Héritier S; Lefrère F; Magalon J; Pengue-Koyi I; Honnet G; Blanche S; Sherman EA; Male F; Berry C; Malani N; Bushman FD; Fischer A; Thrasher AJ; Galy A; Cavazzana M
JAMA; 2015 Apr; 313(15):1550-63. PubMed ID: 25898053
[TBL] [Abstract][Full Text] [Related]
16. Clinical applications of gene therapy for primary immunodeficiencies.
Cicalese MP; Aiuti A
Hum Gene Ther; 2015 Apr; 26(4):210-9. PubMed ID: 25860576
[TBL] [Abstract][Full Text] [Related]
17. Engineering Stem Cells for Biomedical Applications.
Yin PT; Han E; Lee KB
Adv Healthc Mater; 2016 Jan; 5(1):10-55. PubMed ID: 25772134
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic stem cell transplantation for primary immunodeficiencies.
Kang E; Gennery A
Hematol Oncol Clin North Am; 2014 Dec; 28(6):1157-70. PubMed ID: 25459185
[TBL] [Abstract][Full Text] [Related]
19. Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS gene.
Oshima K; Imai K; Albert MH; Bittner TC; Strauss G; Filipovich AH; Morio T; Kapoor N; Dalal J; Schultz KR; Casper JT; Notarangelo LD; Ochs HD; Nonoyama S
J Clin Immunol; 2015 Jan; 35(1):15-21. PubMed ID: 25388447
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
